Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes

Annals of Internal Medicine

Volumn 137, Issue 3, 2002, Pages 156-163

  Molldrem, Jeffrey J ^a   Leifer, Eric ^a   Bahceci, Erkut ^a   Saunthararajah, Yogen ^a   Rivera, Mary ^a   Dunbar, Cynthia ^a   Liu, Johnson ^a   Nakamura, Riotoro ^a   Young, Neal S ^a   Barrett, A John ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BONE MARROW DEPRESSION; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; OUTCOMES RESEARCH; PALLIATIVE THERAPY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0037031289     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-3-200208060-00007     Document Type: Article

References (19)

1. International scoring system for evaluating prognosis in myelodysplastic syndromes
2. Meeting highlights: Therapeutic strategies and supportive care in myelodysplastic syndromes: Yesterday, today and tomorrow
3. Establishing the incidence of myelodysplastic syndrome
4. Primary myelodysplastic syndromes: Diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies
5. The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: An in vitro study
6. T cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes
7. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles
8. Immunosuppressive therapy for hypoplastic myelodysplastic syndrome
9. Antilymphocyte globulin for myelodysplastic syndrome
10. Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow
11. Antithymocyte globulin for patients with myelodysplastic syndrome
12. Proposals for the classification of the myelodysplastic syndromes
13. Nonparametric estimation from incomplete observations
14. A report on the natural duration of cancer
15. Regression models and life tables
16. The pathophysiology of acquired aplastic anemia
17. Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?
18. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome